Gamma Delta T Cell Subset V Gamma 2+ Expansion Associated with Longterm Infliximab Treatment in a Patient with Ankylosing Spondylitis

J Rheumatol. 2016 Nov;43(11):2079-2082. doi: 10.3899/jrheum.160425.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects*
  • Flow Cytometry
  • Humans
  • Infliximab / administration & dosage
  • Infliximab / adverse effects*
  • Intraepithelial Lymphocytes / drug effects*
  • Intraepithelial Lymphocytes / pathology
  • Lymphocytosis / chemically induced*
  • Lymphocytosis / pathology
  • Male
  • Spondylitis, Ankylosing / drug therapy*
  • Young Adult

Substances

  • Antirheumatic Agents
  • Infliximab